Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer
Clinical trial NCT01172223 · COMPLETED
Trial details
- NCT number
- NCT01172223
- Sponsor
- Prof Dirk Elling
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.